A brain, hormone, and metabolic approach to weight and energy - not a quick fix.

GLP-1 Metabolic Support for Women

A personalized GLP-1 program for perimenopause and menopause, focused on metabolism, hormones, and brain function. Not just weight loss.

Starting at $299 /month

Why Weight Management Is Different in Midlife

Addresses hormonal and dopamine shifts impacting weight and energy
Medication prescribed when appropriate and shipped via EllieMD, starting at $299/month
Includes monitoring, dose adjustments, and messaging support through EllieMD

What GLP-1 May Support

Improved insulin sensitivity and blood sugar regulation

Reduced food noise and better appetite control

Decreased systemic inflammation

Dopamine support - particularly relevant for women with ADHD

Improved energy and recovery

Long-term metabolic health and sustainable body composition

Options

As an add-on to Steady Momentum

Or add monthly provider support ($99/month) for ongoing guidance and integration for cash pay patients

Or as an addition to insured appointments

Our Approach

GLP-1 is a tool – not the entire solution. We use it to restore metabolic function and create momentum. Then we support your body with:

  • Protein-forward nutrition to preserve muscle
  • Blood sugar stabilization strategies
  • Strength training recommendations for midlife women
  • Sleep and recovery optimization
  • Hormone-aware care specific to perimenopause and menopause

Optional Add-On: Lab Optimization Package

Recommended for best results. Includes hormone panel, metabolic markers, inflammation markers, and micronutrient insights to personalize your dosing and nutrition strategy.

GLP-1 Metabolic Health Program FAQs

1. What is the GLP-1 Metabolic Program at Steady State Health?

The GLP-1 Metabolic Program is a cash-pay weight, energy, and metabolism program for women in perimenopause and menopause, delivered through Steady State Health and EllieMD. Semaglutide starts at $239/month and tirzepatide at $299/month, with medication shipped directly to the patient. The program includes medical evaluation, ongoing dose adjustments, messaging support, and nutrition guidance specifically designed for the hormonal and metabolic shifts of midlife — not generic weight-loss prescribing.

Most telehealth GLP-1 services prescribe semaglutide or tirzepatide as a standalone weight-loss drug. Steady State Health prescribes GLP-1 inside a perimenopause and menopause framework, integrating it with hormone status, ADHD care, and dopamine regulation. The program targets insulin resistance, inflammation, and energy, and uses nutrition focused on protein and blood sugar stability rather than calorie restriction. The result is a clinical plan that addresses why midlife weight gain happens, not just the number on the scale.

Compounded semaglutide through Steady State Health and EllieMD starts at $239 per month, and compounded tirzepatide starts at $299 per month. The monthly fee includes the medical evaluation, the medication shipped to the patient, ongoing monitoring and dose adjustments, messaging support between visits, and nutrition and lifestyle guidance. The optional Lab Optimization Package adds hormone, metabolic, inflammation, and micronutrient testing for $429.

No. The GLP-1 program is cash-pay only and is not billed to insurance. Payment is required before scheduling. The program is also restricted to patients located in Oregon and Washington. Patients with insurance coverage for branded semaglutide (Wegovy, Ozempic) or tirzepatide (Mounjaro, Zepbound) usually pursue that pathway through their primary care or endocrinologist instead, although those paths often lack the perimenopause-specific clinical framing.

Semaglutide ($239/month) acts on a single GLP-1 receptor and is the longer-established medication with a deep evidence base for weight, blood sugar, and appetite regulation. Tirzepatide ($299/month) is dual-action, hitting both GLP-1 and GIP receptors, and tends to produce stronger metabolic and weight effects in clinical trials. Steady State Health helps patients choose based on medical history, response to prior therapies, and budget — there is no default recommendation.

Yes. The GLP-1 program is available as a standalone cash-pay program for Oregon and Washington patients with monthly provider support at $99/month. It can also be added to Steady Momentum or layered onto Insurance-Based Care visits. Most patients who want both metabolic and hormonal care choose to combine GLP-1 with Steady Momentum so the plan is integrated, but this is a recommendation rather than a requirement.

Current evidence supports long-term GLP-1 use for metabolic and weight management when monitored by a clinician, and the medications are not specifically contraindicated in perimenopause. Steady State Health requires ongoing monitoring, dose adjustments, and lab review during the program rather than indefinite refills. Women with personal or family history of medullary thyroid carcinoma, MEN2, or pancreatitis are not candidates, and the medical evaluation screens for these conditions before prescribing.

GLP-1 programs are cash pay only. Insurance is not billed. Payment is required before scheduling. Available to patients in Oregon and Washington only.